320 related articles for article (PubMed ID: 18685064)
1. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
Wang D; Strandgaard S; Iversen J; Wilcox CS
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.
Wang D; Strandgaard S; Borresen ML; Luo Z; Connors SG; Yan Q; Wilcox CS
Am J Kidney Dis; 2008 Feb; 51(2):184-91. PubMed ID: 18215696
[TBL] [Abstract][Full Text] [Related]
3. NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.
Wang C; Luo Z; Carter G; Wellstein A; Jose PA; Tomlinson J; Leiper J; Welch WJ; Wilcox CS; Wang D
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R399-R406. PubMed ID: 29167164
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
Wang D; Gill PS; Chabrashvili T; Onozato ML; Raggio J; Mendonca M; Dennehy K; Li M; Modlinger P; Leiper J; Vallance P; Adler O; Leone A; Tojo A; Welch WJ; Wilcox CS
Circ Res; 2007 Sep; 101(6):627-35. PubMed ID: 17673667
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
8. Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome.
Korandji C; Zeller M; Guilland JC; Collin B; Lauzier B; Sicard P; Duvillard L; Goirand F; Moreau D; Cottin Y; Rochette L; Vergely C
Atherosclerosis; 2011 Feb; 214(2):310-5. PubMed ID: 21146169
[TBL] [Abstract][Full Text] [Related]
9. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
[TBL] [Abstract][Full Text] [Related]
10. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats.
Hsu CN; Huang LT; Lau YT; Lin CY; Tain YL
Transl Res; 2012 Feb; 159(2):90-8. PubMed ID: 22243793
[TBL] [Abstract][Full Text] [Related]
11. The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage.
Szlachcic A; Krzysiek-Maczka G; Pajdo R; Targosz A; Magierowski M; Jasnos K; Drozdowicz D; Kwiecien S; Brzozowski T
Curr Pharm Des; 2013; 19(1):90-7. PubMed ID: 22950506
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
14. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
15. Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.
Lüneburg N; Xanthakis V; Schwedhelm E; Sullivan LM; Maas R; Anderssohn M; Riederer U; Glazer NL; Vasan RS; Böger RH
J Nutr; 2011 Dec; 141(12):2186-90. PubMed ID: 22031661
[TBL] [Abstract][Full Text] [Related]
16. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
Cheng MC; Wu TH; Huang LT; Tain YL
Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
[TBL] [Abstract][Full Text] [Related]
18. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats.
Tain YL; Huang LT; Lin IC; Lau YT; Lin CY
J Pineal Res; 2010 Nov; 49(4):390-8. PubMed ID: 20950359
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats.
Xiong Y; Yuan LW; Deng HW; Li YJ; Chen BM
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):842-7. PubMed ID: 11553026
[TBL] [Abstract][Full Text] [Related]
20. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
Jepson RE; Syme HM; Vallance C; Elliott J
J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
